Abstract
Seseorang yang mengalami stunting saat balita cenderung memiliki tubuh yang lebih pendek dan memiliki risiko efek jangka panjang, yaitu menderita penyakit kronis yang berkaitan dengan gizi, rentan terhadap penumpukkan lemak tubuh, serta berisiko menderita diabetes melitus karena resistensi insulin dan beberapa penyakit tidak menular seperti hipertensi dan stroke. Oleh karena itu, penelitian ini dilakukan untuk menelaah secara ilmiah efek stunting yang terjadi pada seseorang saat balita terhadap penyakit tidak menular saat dewasa. Penelitian ini merupakan literature review dengan metode PICO (population, intervention, comparators and outcome). Database elektronik yang digunakan adalah Embase, Proquest dan lib.ui didapatkan sebanyak lima artikel dan satu tugas akhir (tesis) setelah melalui tahapan eksklusi berdasarkan kriteria yang telah ditetapkan. Usia anak yang dijadikan sampel dalam setiap studi berkisar dua sampai lima tahun. Hasil telaah ilmiah dari lima artikel dan satu tugas akhir yang sesuai dengan kriteria inklusi, menunjukkan bahwa seseorang yang mengalami stunting saat balita memiliki risiko kegemukan atau obesitas. Adanya fase catch up growth untuk mengejar ketertinggalan pertumbuhan dan resistensi insulin sehingga rentan terhadap penumpukkan lemak tubuh. Stunting yang dialami seseorang pada saat balita dapat menjadi salah satu faktor seseorang menderita penyakit kronis yang berkaitan dengan gizi dan penyakit tidak menular lainnya karena adanya peningkatan adipositas dan penumpukkan lemak tubuh. Perlu dilakukan telaah lebih mendalam pada penelitian selanjutnya terkait efek genetik dan perubahan hormon pada masa remaja karena pada masa ini seseorang mengalami fase pubertas dan dapat mempengaruhi risiko obesitas dan hipertensi di masa dewasa.
References
1. WHO. Levels and Trends in Child Malnutrition UNICEF /WHO / World Bank Group Joint Child Malnutrition EstimatesKey findings of The 2021 Edition, https://www.who.int/publications/i/item/9789240025257 (2021).
2. Sudikno, Irawan I raswanti, Setyawati B, et al. Laporan AkhirPenelitian Studi Status Gizi Balita Di Indonesia Tahun 2019,https://cegahstunting.id/unduhan/publikasi-data/ (2019).
3. Dewey KG, Begum K. Long-term consequences of stuntingin early life. Matern Child Nutr 2011; 7: 5–18.
4. Victoria C, Adair L, Fall C, et al. Maternal and ChildUndernutrition 2/ : Maternal and child ... Lancet 2008; 371:340–357.
5. Achadi EL, Achadi A, Aninditha T. Pencegahan Stunting:Pentingnya Peran 1000 Hari Pertama Kehidupan. Edisi 1, C.Depok: Rajawali Pers, 2021.
6. Kementerian Koordinator Bidang Kesejahteraan Rakyat.Kerangka Kebijakan Gerakan Nasional PercepatanPerbaikan Gizi dalam Rangka Seribu Hari PertamaKehidupan (Gerakan 1000 HPK). Jakarta, 2013.
7. Rappaport SM. Genetic Factors Are Not The Major Causes ofChronic Diseases. PLoS One 2016; 11: 1–9.
8. Williams JP. Catch-up growth. J Embryol exp Morph Vol 65(Supplement), pp 1981; 65: 89–101.
9. Prentice AM, Ward KA, Goldberg GR, et al. Critical windowsfor nutritional interventions against stunting. Am J Clin Nutr2013; 97: 911–918.
10. Georgiadis A, Penny ME. Child undernutrition:opportunities beyond the first 1000 days. Lancet Public Heal2017; 2: e399.
11. McIntyre MH. Adult stature, body proportions and age atmenarche in the United States National Health and NutritionSurvey (NHANES) III. Ann Hum Biol 2011; 38: 716–720.
12. Victora CG, Adair L, Fall C, et al. Maternal and childundernutrition: consequences for adult health and humancapital. Lancet (London, England) 2008; 371: 340–357.
13. Kajubi SK. The Endocrine Pancreas After Kwashiorkor. AmJ Clin Nutr 1972; 25: 1140–1142.
14. Soliman AT, ElZalabany MM, Salama M, et al. Serum LeptinConcentrations During Severe Protein-Energy Malnutrition:Correlation with Growth Parameters and Endocrine Function.Metabolism 2000; 49: 819–825.
15. Matrins VJB, Toledo Florêncio TMM, Grillo LP, et al. Longlasting effects of undernutrition. Int J Environ Res PublicHealth 2011; 8: 1817–1846.
16. Sung KC, Reaven GM, Kim SH. Utility of homeostasis modelassessment of â-cell function in predicting diabetes in12,924 healthy Koreans. Diabetes Care 2010; 33: 200–202.
17. Bréant B, Gesina E, Blondeau B. Nutrition, glucocorticoidsand pancreas development. Horm Res 2006; 65 Suppl 3: 98–104.
18. Barker DJP, Gelow J, Thornburg K, et al. The early origins ofchronic heart failure: Impaired placental growth andinitiation of insulin resistance in childhood. Eur J Heart Fail2010; 12: 819–825
19. Soliman A, Sanctis V De, Alaaraj N, et al. Early and Longterm Consequences of Nutritional Stunting: From Childhoodto Adulthood. Acta Biomed 2021; Vol 92, N1 2021; 1: 1–12.
20. Sawaya AL, Sesso R, Florêncio TMDMT, et al. Associationbetween chronic undernutrition and hypertension. Maternaland Child Nutrition 2005; 1: 155–163.
21. Rasyid H, Bakri S. Intra-uterine Growth Retardation andDevelopment of Hypertension. Acta Med Indones 2016; 48:320–324.
22. Franco MCP, Casarini DE, Carneiro-Ramos MS, et al.Circulating renin-angiotensin system and catecholaminesin childhood: is there a role for birthweight? Clin Sci (Lond)2008; 114: 375–380.
23. Fernandes MTB, Sesso R, Martins PA, et al. Increased bloodpressure in adolescents of low socioeconomic status withshort stature. Pediatr Nephrol 2003; 18: 435–439.
24. Henriksen EJ. Modulation of metabolic control byangiotensin converting enzyme (ACE) inhibition. J CellPhysiol 2003; 196: 171–179.
25. Rivière G, et al. Angiotensin-converting enzyme 2 (ACE2)and ACE activities display tissue-specific sensitivity toundernutrition-programmed hypertension in the adult rat.Hypertens (Dallas, Tex 1979) 2005; 46: 1169–1174.
26. Ceravolo GS, et al. Enalapril and losartan restored bloodpressure and vascular reactivity in intrauterineundernourished rats. Life Sci 2007; 80: 782–787.
27. Cambien F, Léger J, Mallet C, et al. Angiotensin I-convertingenzyme gene polymorphism modulates the consequencesof in utero growth retardation on plasma insulin in youngadults. Diabetes 1998; 47: 470–475.
28. Franco MCP, et al. Homocysteine and Nitric Oxide AreRelated to Blood Pressure and Vascular Function in Smallfor-Gestational-Age Children. Hypertension 2007; 50: 396–402.
29. Schreuder M, et al. Consequences of intrauterine growthrestriction for the kidney. Kidney Blood Press Res 2006; 29:108–125.
30. Langley-Evans SC. Intrauterine programming ofhypertension by glucocorticoids. Life Sci 1997; 60: 1213–1221.
31. Sherman RC, Langley-Evans SC. Early administration ofangiotensin-converting enzyme inhibitor captopril, preventsthe development of hypertension programmed byintrauterine exposure to a maternal low-protein diet in therat. Clin Sci (Lond) 1998; 94: 373–381.
32. Febba A, Sesso R, Barreto GP, et al. Stunting growth:Association of the blood pressure levels and ACE activity inearly childhood. Pediatr Nephrol 2009; 24: 379–386.
33. Sawaya AL, Grillo LP, Verreschi I, et al. Mild stunting isassociated with higher susceptibility to the effects of highfat diets: Studies in a shantytown population in Sao Paulo,Brazil. J Nutr 1998; 128: 415–420.
34. Sichieri R, Siqueira KS, Moura AS. Obesity and abdominalfatness associated with undernutrition early in life in a surveyin Rio de Janeiro. Int J Obes Relat Metab Disord J Int AssocStudy Obes 2000; 24: 614–618.
35. Bénéfice E, et al. Relationship between stunting in infancyand growth and fat distribution during adolescence inSenegalese girls. Eur J Clin Nutr 2001; 55: 50–58.41. Faisal DR. Pengaruh Status Gizi Stunting Saat Balita danObesitas Terhadap Hipertensi. Universitas Indonesia, 2019.
36. Kamioka H. Preferred Reporting Items for SystematicReview and Meta-Analysis Protocols (PRISMA-P) 2015Statement. Japanese Pharmacol Ther 2019; 47: 1177–1185.
37.Higgins J and GS.8_Assessing_Risk_of_Bias_in_Included_Studies @Handbook.Cochrane.Org, https://handbook-5-1 . c o c h r a n e . o r g / c h a p t e r _ 8 /8_assessing_risk_of_bias_in_included_studies.htm%0Ahttp:// h a n d b o o k . c o c h r a n e . o r g / c h a p t e r _ 8 /8_assessing_risk_of_bias_in_included_studies.htm (2011).
38. Walker SP, Chang SM, Powell CA. The association betweenearly childhood stunting and weight status in late adolescence.Int J Obes 2007; 31: 347–352.
39. Wells JCK, Devakumar D, Manandhar DS, et al. Associationsof stunting at 2 years with body composition and bloodpressure at 8 years of age: longitudinal cohort analysis fromlowland Nepal. Eur J Clin Nutr 2019; 73: 302–310.
40. Asiki G, Newton R, Marions L, et al. The effect of childhoodstunting and wasting on adolescent cardiovascular diseasesrisk and educational achievement in rural Uganda: aretrospective cohort study. Global Health Action; 12. Epubahead of print 2019. DOI: 10.1080/16549716.2019.1626184.
42. Simbolon D. Model Prediksi Indeks Massa Tubuh RemajaBerdasarkan Riwayat Lahir dan Status Gizi Anak. Kesmas NatlPublic Heal J 2013; 8: 19.
43. Monteiro et al. Obesity in Developing Countries/ :Biological and Ecological Factors Independent Effects ofIncome and Education on the Risk of Obesity in the BrazilianAdult Population 1. 2001.
44. Barker DJ. The long-term outcome of retarded fetal growth.Clin Obstet Gynecol 1997; 40: 853–863.
45. Martins PA, Hoffman DJ, Fernandes MTB, et al. Stuntedchildren gain less lean body mass and more fat mass thantheir non-stunted counterparts: a prospective study. Br JNutr 2004; 92: 819–825.
46. Hoffman DJ, Sawaya AL, Verreschi I, et al. Why arenutritionally stunted children at increased risk of obesity?Studies of metabolic rate and fat oxidation in shantytownchildren from São Paulo, Brazil. Am J Clin Nutr 2000; 72:702–707.
47. Bennett F, Watson-Brown C, Thame M, et al. Shortness atbirth is associated with insulin resistance in pre-pubertalJamaican children. Eur J Clin Nutr 2002; 56: 506–511.
48. Bennett FI, Walker SP, Gaskin P, et al. Fasting levels of serumglucose, cholesterol and triglyceride at age eleven to twelveyears in stunted and non-stunted Jamaican children. ActaPaediatr 2002; 91: 903–908.
49. Walker SP, Gaskin PS, Powell CA, et al. The effects of birthweight and postnatal linear growth retardation on body massindex, fatness and fat distribution in mid and late childhood.Public Health Nutr 2002; 5: 391–396.
50. Finelli C, Sommella L, Gioia S, et al. Should visceral fat bereduced to increase longevity? Ageing Res Rev 2013; 12:996–1004.
51. Lebovitz HE, Banerji MA. Point: visceral adiposity iscausally related to insulin resistance. Diabetes Care 2005;28: 2322–2325.
52. Hardy OT, Czech MP, Corvera S. What causes the insulinresistance underlying obesity? Curr Opin Endocrinol DiabetesObes 2012; 19: 81–87.
53. Phillips DI, Walker BR, Reynolds RM, et al. Low birthweight predicts elevated plasma cortisol concentrations inadults from 3 populations. Hypertens (Dallas, Tex 1979)2000; 35: 1301–1306.
54. Kajantie E, Phillips DIW, Andersson S, et al. Size at birth,gestational age and cortisol secretion in adult life: foetalprogramming of both hyper- and hypocortisolism? ClinEndocrinol (Oxf) 2002; 57: 635–641.
55. Kajantie E, Eriksson J, Barker DJP, et al. Birthsize, gestationalage and adrenal function in adult life: studies ofdexamethasone suppression and ACTH1-24 stimulation. EurJ Endocrinol 2003; 149: 569–575.
56. Björntorp P. Do stress reactions cause abdominal obesityand comorbidities? Obes Rev an Off J Int Assoc Study Obes2001; 2: 73–86.
57. Drapeau V, Therrien F, Richard D, et al. Is visceral obesitya physiological adaptation to stress? Panminerva Med 2003;45: 189–195.
58. Wallerius S, Rosmond R, Ljung T, et al. Rise in morningsaliva cortisol is associated with abdominal obesity in men:a preliminary report. J Endocrinol Invest 2003; 26: 616–619.
59. Kruger HS, Pretorius R, Schutte AE. Stunting, adiposity, andlow-grade inflammation in African adolescents from atownship high school. Nutrition 2010; 26: 90–99.
60. Masuzaki H, Paterson J, Shinyama H, et al. A transgenicmodel of visceral obesity and the metabolic syndrome.Science 2001; 294: 2166–2170.
61. Richard D, Chapdelaine S, Deshaies Y, et al. Energy balanceand lipid metabolism in transgenic mice bearing an antisenseGCR gene construct. Am J Physiol 1993; 265: R146-50.
62. Hanson SK, Munthali RJ, Lundeen EA, et al. Stunting at 24months is not related to incidence of overweight throughyoung adulthood in an urban South African birth cohort. JNutr 2018; 148: 967–973.
63. Clemente APG, Santos CD, Silva AAB, et al. Mild stunting isassociated with higher blood pressure in overweightadolescents. Arq Bras Cardiol 2012; 98: 6–12.
64. Gaskin PS, Walker SP, Forrester TE, et al. Early linear growthretardation and later blood pressure. Eur J Clin Nutr 2000;54: 563–567.
65. Wells JCK, Devakumar D, Grijalva-Eternod CS, et al. Bloodpressure and the capacity-load model in 8-year-old childrenfrom Nepal: Testing the contributions of kidney size andintergenerational effects. Am J Hum Biol Off J Hum Biol Counc2016; 28: 555–565.
66. Saenger P. Dose effects of growth hormone during puberty.Horm Res 2003; 60: 52–57.
67. Yaya S, Uthman OA, Kunnuji M, et al. Does economic growthreduce childhood stunting? A multicountry analysis of 89Demographic and Health Surveys in sub-Saharan Africa. BMJGlob Heal 2020; 5: e002042–e002042
Recommended Citation
Kurniati, Henny; Djuwita, Ratna; and Istiqfani, Maulidya
(2022)
"Tinjauan Literatur : Stunting Saat Balita sebagai Salah Satu Faktor Risiko Penyakit Tidak Menular di Masa Depan,"
Jurnal Epidemiologi Kesehatan Indonesia: Vol. 6:
Iss.
2, Article 2.
DOI: 10.7454/epidkes.v6i2.6349
Available at:
https://scholarhub.ui.ac.id/epidkes/vol6/iss2/2
Included in
International and Community Nutrition Commons, Public Health Education and Promotion Commons, Reproductive and Urinary Physiology Commons
